Vermeire S - Search Results

1

Enhancing probiotic impact: engineering Saccharomyces boulardii for optimal acetic acid production and gastric passage tolerance.

de Carvalho BT, Subotić A, Vandecruys P, Deleu S, Vermeire S, Thevelein JM. de Carvalho BT, et al. Among authors: vermeire s. Appl Environ Microbiol. 2024 May 16:e0032524. doi: 10.1128/aem.00325-24. Online ahead of print. Appl Environ Microbiol. 2024. PMID: 38752748 Free article.

2

Forecasted infliximab concentrations during induction predict time to remission and sustained disease control of inflammatory bowel disease.

Vermeire S, Dubinsky MC, Rabizadeh S, Panetta JC, Spencer EA, Dreesen E, D'Haens G, Dervieux T, Laharie D. Vermeire S, et al. Clin Res Hepatol Gastroenterol. 2024 May 13;48(6):102374. doi: 10.1016/j.clinre.2024.102374. Online ahead of print. Clin Res Hepatol Gastroenterol. 2024. PMID: 38750934

3

EFFICACY AND SAFETY OF USTEKINUMAB FOR CHRONIC POUCHITIS: A PROSPECTIVE OPEN-LABEL MULTICENTER STUDY.

Outtier A, Louis E, Dewit O, Reenaers C, Schops G, Lenfant M, Pontus E, De Hertogh G, Verstockt B, Sabino J, Vermeire S, Ferrante M. Outtier A, et al. Among authors: vermeire s. Clin Gastroenterol Hepatol. 2024 May 13:S1542-3565(24)00438-5. doi: 10.1016/j.cgh.2024.04.030. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38750870

4

Fibrostricturing Crohn's disease is marked by an increase in active eosinophils in the deeper layers.

Jacobs I, Ke BJ, Ceulemans M, Cremer J, D'Hoore A, Bislenghi G, Matteoli G, De Hertogh G, Sabino J, Ferrante M, Vermeire S, Breynaert C, Vanuytsel T, Verstockt B. Jacobs I, et al. Among authors: vermeire s. Clin Transl Gastroenterol. 2024 May 1. doi: 10.14309/ctg.0000000000000706. Online ahead of print. Clin Transl Gastroenterol. 2024. PMID: 38690831

5

Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.

Alsoud D, Moes DJAR, Wang Z, Soenen R, Layegh Z, Barclay M, Mizuno T, Minichmayr IK, Keizer RJ, Wicha SG, Wolbink G, Lambert J, Vermeire S, de Vries A, Papamichael K, Padullés-Zamora N, Dreesen E. Alsoud D, et al. Among authors: vermeire s. Ther Drug Monit. 2024 Jun 1;46(3):291-308. doi: 10.1097/FTD.0000000000001204. Epub 2024 Apr 17. Ther Drug Monit. 2024. PMID: 38648666 Review.

6

Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme.

Peyrin-Biroulet L, Dubinsky MC, Sands BE, Panés J, Schreiber S, Reinisch W, Feagan BG, Danese S, Yarur AJ, D'Haens GR, Goetsch M, Wosik K, Keating M, Lazin K, Wu J, Modesto I, McDonnell A, Bartolome L, Vermeire S. Peyrin-Biroulet L, et al. Among authors: vermeire s. J Crohns Colitis. 2024 Apr 13:jjae038. doi: 10.1093/ecco-jcc/jjae038. Online ahead of print. J Crohns Colitis. 2024. PMID: 38613425

7

Effect of Weave and Weft Type on Mechanical and Comfort Properties of Hemp-Linen Fabrics.

Vasile S, Vermeire S, Vandepitte K, Troch V, De Raeve A. Vasile S, et al. Among authors: vermeire s. Materials (Basel). 2024 Apr 3;17(7):1650. doi: 10.3390/ma17071650. Materials (Basel). 2024. PMID: 38612162 Free PMC article.

8

Ustekinumab and Vedolizumab Exposure Is Unaffected by Pharmacogenetic Determinants of Anti-TNFs Pharmacokinetics.

Alsoud D, Verstockt B, Vermeire S. Alsoud D, et al. Among authors: vermeire s. Inflamm Bowel Dis. 2024 May 2;30(5):874-875. doi: 10.1093/ibd/izae035. Inflamm Bowel Dis. 2024. PMID: 38581670 No abstract available.

9

Simulated cost-effectiveness of a novel precision-guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy.

Alizadeh ER, Dervieux T, Vermeire S, Dubinsky M, D'Haens G, Laharie D, Shim A, Vaughn BP. Alizadeh ER, et al. Among authors: vermeire s. Pharmacotherapy. 2024 Apr;44(4):331-342. doi: 10.1002/phar.2915. Epub 2024 Apr 4. Pharmacotherapy. 2024. PMID: 38576238

10

Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease.

Harris S, Feagan BG, Hanauer S, Vermeire S, Ghosh S, Yan J, Wu C, Hu Y, Maddux R, Wolf DC, D'Haens G. Harris S, et al. Among authors: vermeire s. Dig Dis Sci. 2024 Apr 3. doi: 10.1007/s10620-024-08391-z. Online ahead of print. Dig Dis Sci. 2024. PMID: 38568396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

863 results

Search Page